Publication Information

{'id': 'https://openalex.org/W2063604495', 'doi': 'https://doi.org/10.1517/13543776.5.10.1007', 'title': 'Editorial Central & Peripheral Nervous Systems: Will neuropeptide Y receptor antagonists offer new therapeutic approaches?', 'display_name': 'Editorial Central & Peripheral Nervous Systems: Will neuropeptide Y receptor antagonists offer new therapeutic approaches?', 'publication_year': 1995, 'publication_date': '1995-10-01', 'ids': {'openalex': 'https://openalex.org/W2063604495', 'doi': 'https://doi.org/10.1517/13543776.5.10.1007', 'mag': '2063604495'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543776.5.10.1007', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S3784663', 'display_name': 'Expert Opinion on Therapeutic Patents', 'issn_l': '1354-3776', 'issn': ['1354-3776', '1744-7674'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5013489323', 'display_name': 'Lars Grundemar', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I187531555', 'display_name': 'Lund University', 'ror': 'https://ror.org/012a77v79', 'country_code': 'SE', 'type': 'education', 'lineage': ['https://openalex.org/I187531555']}], 'countries': ['SE'], 'is_corresponding': True, 'raw_author_name': 'Lars Grundemar', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Lund University Hospital, S-221 85, Lund, Sweden'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Lund University Hospital, S-221 85, Lund, Sweden', 'institution_ids': ['https://openalex.org/I187531555']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5013489323'], 'corresponding_institution_ids': ['https://openalex.org/I187531555'], 'apc_list': None, 'apc_paid': None, 'fwci': 0.121, 'has_fulltext': False, 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.247001, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 68, 'max': 70}, 'biblio': {'volume': '5', 'issue': '10', 'first_page': '1007', 'last_page': '1013'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10814', 'display_name': 'Neuropeptides and Animal Physiology', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10814', 'display_name': 'Neuropeptides and Animal Physiology', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11178', 'display_name': 'Receptor Mechanisms and Signaling', 'score': 0.9871, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13338', 'display_name': 'Pharmacological Effects and Assays', 'score': 0.9811, 'subfield': {'id': 'https://openalex.org/subfields/1103', 'display_name': 'Animal Science and Zoology'}, 'field': {'id': 'https://openalex.org/fields/11', 'display_name': 'Agricultural and Biological Sciences'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/peptide-yy', 'display_name': 'Peptide YY', 'score': 0.8197987}], 'concepts': [{'id': 'https://openalex.org/C93984277', 'wikidata': 'https://www.wikidata.org/wiki/Q24782073', 'display_name': 'Neuropeptide Y receptor', 'level': 4, 'score': 0.90421945}, {'id': 'https://openalex.org/C2780796126', 'wikidata': 'https://www.wikidata.org/wiki/Q290293', 'display_name': 'Peptide YY', 'level': 5, 'score': 0.8197987}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.74111027}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.55608296}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5307037}, {'id': 'https://openalex.org/C75908981', 'wikidata': 'https://www.wikidata.org/wiki/Q28578', 'display_name': 'Appetite', 'level': 2, 'score': 0.5115686}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.46794692}, {'id': 'https://openalex.org/C135285700', 'wikidata': 'https://www.wikidata.org/wiki/Q38173', 'display_name': 'G protein-coupled receptor', 'level': 3, 'score': 0.4458191}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34558156}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.32412174}, {'id': 'https://openalex.org/C118303440', 'wikidata': 'https://www.wikidata.org/wiki/Q419968', 'display_name': 'Neuropeptide', 'level': 3, 'score': 0.276735}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1517/13543776.5.10.1007', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S3784663', 'display_name': 'Expert Opinion on Therapeutic Patents', 'issn_l': '1354-3776', 'issn': ['1354-3776', '1744-7674'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320547', 'host_organization_name': 'Taylor & Francis', 'host_organization_lineage': ['https://openalex.org/P4310320547'], 'host_organization_lineage_names': ['Taylor & Francis'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 37, 'referenced_works': ['https://openalex.org/W1502386136', 'https://openalex.org/W1604152302', 'https://openalex.org/W1968793572', 'https://openalex.org/W1977904778', 'https://openalex.org/W1982270374', 'https://openalex.org/W1983467726', 'https://openalex.org/W1987294827', 'https://openalex.org/W1992340762', 'https://openalex.org/W1993010689', 'https://openalex.org/W1997723676', 'https://openalex.org/W1998134451', 'https://openalex.org/W2002538071', 'https://openalex.org/W2010256902', 'https://openalex.org/W2015301110', 'https://openalex.org/W2017763577', 'https://openalex.org/W2020128704', 'https://openalex.org/W2024975131', 'https://openalex.org/W2025875108', 'https://openalex.org/W2026077934', 'https://openalex.org/W2031733841', 'https://openalex.org/W2039466603', 'https://openalex.org/W2039867362', 'https://openalex.org/W2041624270', 'https://openalex.org/W2048909957', 'https://openalex.org/W2051394957', 'https://openalex.org/W2059984021', 'https://openalex.org/W2061930496', 'https://openalex.org/W2062636887', 'https://openalex.org/W2074070896', 'https://openalex.org/W2076501972', 'https://openalex.org/W2077143781', 'https://openalex.org/W2078012887', 'https://openalex.org/W2079803201', 'https://openalex.org/W2081574164', 'https://openalex.org/W2125796423', 'https://openalex.org/W2161990209', 'https://openalex.org/W4319054550'], 'related_works': ['https://openalex.org/W3172178442', 'https://openalex.org/W3094866106', 'https://openalex.org/W2093393589', 'https://openalex.org/W2092917543', 'https://openalex.org/W2079254960', 'https://openalex.org/W2055277135', 'https://openalex.org/W2041247287', 'https://openalex.org/W2034986159', 'https://openalex.org/W1998134451', 'https://openalex.org/W1579260763'], 'abstract_inverted_index': {'Neuropeptide': [0], 'Y': [1], '(NPY)': [2], 'and': [3, 12, 26, 38, 55, 64, 78, 95, 112, 117, 140, 180, 206, 222], 'its': [4], 'receptors': [5, 194], 'are': [6, 100, 129], 'widely': [7], 'distributed': [8], 'in': [9, 33, 72, 101, 131, 254], 'the': [10, 27, 42, 102, 132, 135, 199, 234, 241], 'central': [11, 63], 'peripheral': [13, 65], 'nervous': [14], 'systems.': [15], 'A': [16], 'multitude': [17], 'of': [18, 35, 41, 46, 62, 90, 104, 115, 134, 138, 142, 164, 201, 210, 231, 236], 'biological': [19], 'effects': [20], 'have': [21, 92, 123, 174, 215], 'been': [22, 93, 125, 175, 216], 'attributed': [23], 'to': [24, 58, 145, 177, 218], 'NPY,': [25], 'peptide': [28, 82, 116], 'is,': [29], 'for': [30, 149, 167, 198, 233], 'instance,': [31], 'involved': [32, 71], 'regulation': [34], 'food': [36, 159], 'intake': [37, 160], 'is': [39, 51, 56, 161, 227], 'one': [40], 'most': [43], 'potent': [44, 53, 211], 'stimuli': [45], 'ingestive': [47], 'behaviour.': [48], 'Moreover,': [49], 'it': [50], 'a': [52, 60, 113, 162, 228], 'vasoconstrictor': [54, 223], 'believed': [57], 'be': [59, 70, 146, 196, 249], 'regulator': [61], 'cardiovascular': [66, 79, 237], 'function.': [67], 'NPY': [68, 110, 120, 139, 155, 171, 185, 193, 212, 244], 'may': [69], 'pathophysiological': [73], 'states,': [74], 'like': [75], 'eating': [76], 'disorders': [77, 238], 'diseases.': [80], 'The': [81, 152], 'acts': [83], 'at': [84], 'multiple': [85], 'G-protein': [86], 'coupled': [87], 'receptors,': [88], 'several': [89], 'which': [91, 107, 157, 188], 'cloned': [94], 'sequenced.': [96], 'Many': [97], 'pharmaceutical': [98], 'companies': [99], 'process': [103], 'developing': [105], 'drugs': [106, 232], 'act': [108, 189], 'on': [109, 191, 240], 'targets,': [111], 'number': [114], 'non-peptide': [118], 'based': [119], 'receptor': [121, 172, 186, 213, 245], 'antagonists': [122, 173, 187, 214, 246], 'recently': [124], 'described.': [126], 'Such': [127], 'compounds': [128], 'essential': [130], 'investigation': [133], 'physiological': [136], 'role': [137], 'some': [141], 'them': [143], 'appear': [144], 'promising': [147], 'leads': [148], 'drug': [150, 168], 'development.': [151, 169], 'specific': [153], 'hypothalamic': [154, 192], 'receptor,': [156], 'mediates': [158], 'target': [163], 'major': [165], 'interest': [166], 'Some': [170], 'shown': [176, 217], 'inhibit': [178], 'NPY-evoked': [179], 'natural': [181], 'feeding': [182], 'response.': [183], 'Similarly,': [184], 'specifically': [190], 'could': [195, 247], 'evaluated': [197], 'treatment': [200, 235], 'anorexia': [202], 'or': [203], 'bulimia': [204], 'nervosa': [205], 'obesity.': [207], 'Another': [208], 'set': [209], 'block': [219], 'NPY-mediated': [220], 'pressor': [221], 'responses.': [224], 'Although': [225], 'there': [226], 'large': [229], 'arsenal': [230], 'already': [239], 'market,': [242], 'vascular': [243], 'also': [248], 'examined': [250], 'as': [251], 'alternative': [252], 'therapeutics': [253], 'this': [255], 'area.': [256]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2063604495', 'counts_by_year': [], 'updated_date': '2024-12-11T17:41:39.324304', 'created_date': '2016-06-24'}